|View printer-friendly version|
|Xerium Technologies Announces Review of Strategic Alternatives to Maximize Shareholder Value|
There can be no assurance that the Board’s strategic review will result in any transaction, or any assurance as to its outcome or timing.
The Company does not intend to disclose or comment on developments related to its review unless and until the Board has approved a specific transaction or otherwise determined that further disclosure is appropriate.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this press release are forward-looking statements
that involve risks and uncertainties, predict or describe future events
or trends and that do not relate solely to historical facts within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
statements include, but are not limited to, statements regarding the
Company’s process to review strategic alternatives and its ability to
maximize shareholder value through such a process. Words such as
“believe,” “expect,” “may,” “will,” “anticipate,” “intend,” “estimate,”
“project,” “plan,” “assume,” “seek to” or other similar expressions or
the negative of these expressions, although not all forward-looking
statements, are used to identify these forward-looking statements.
Actual results may differ materially from those discussed in
forward-looking statements as a result of factors, risks and
uncertainties over many of which we have no control. With respect to the
Company’s review of strategic alternatives, there is no assurance that
the process will result in any transaction or other action by the
Company, that any transaction or other action will be consummated, or
that any transaction or other action will maximize stockholder value.
These factors, risks and uncertainties include, but are not limited to:
the economic strength and competitive nature of the geographic markets
that the Company serves; the Company’s ability to increase manufacturing
capacity and productivity; the Company’s ability to increase the
Company’s selling prices during periods of increasing raw material
costs; the impact of foreign currency exchange rate fluctuations;
compliance with U.S. and foreign laws, including the Foreign Corrupt
Practices Act; the impact of the announcement of the review of strategic
alternatives on the Company’s business, its financial and operating
results and its employees and customers; factors affecting the
feasibility and timing of any transaction or other action; the ability
to identify and close any transaction; risks related to realization of
the expected benefits of any transaction or other action to the Company
and its stockholders; and the other risks detailed from time to time in
the Company’s filings with the
Xerium Technologies, Inc.